nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—DRD4—conduct disorder	0.411	0.485	CbGaD
Asenapine—SLC6A4—conduct disorder	0.247	0.291	CbGaD
Asenapine—HTR2A—conduct disorder	0.19	0.224	CbGaD
Asenapine—HTR7—autonomic nervous system—conduct disorder	0.00386	0.199	CbGeAlD
Asenapine—HTR2A—autonomic nervous system—conduct disorder	0.00241	0.124	CbGeAlD
Asenapine—HTR5A—brain—conduct disorder	0.0024	0.123	CbGeAlD
Asenapine—Amoxapine—DRD4—conduct disorder	0.00156	0.272	CrCbGaD
Asenapine—Loxapine—DRD4—conduct disorder	0.00122	0.213	CrCbGaD
Asenapine—DRD4—brain—conduct disorder	0.00119	0.0611	CbGeAlD
Asenapine—HTR1E—brain—conduct disorder	0.00102	0.0527	CbGeAlD
Asenapine—Amoxapine—SLC6A4—conduct disorder	0.000935	0.163	CrCbGaD
Asenapine—DRD3—brain—conduct disorder	0.000834	0.043	CbGeAlD
Asenapine—HTR6—brain—conduct disorder	0.000803	0.0414	CbGeAlD
Asenapine—HRH2—brain—conduct disorder	0.000734	0.0378	CbGeAlD
Asenapine—Loxapine—SLC6A4—conduct disorder	0.00073	0.128	CrCbGaD
Asenapine—Amoxapine—HTR2A—conduct disorder	0.000718	0.126	CrCbGaD
Asenapine—DRD1—brain—conduct disorder	0.000597	0.0308	CbGeAlD
Asenapine—Loxapine—HTR2A—conduct disorder	0.000561	0.0981	CrCbGaD
Asenapine—HTR1B—brain—conduct disorder	0.000484	0.0249	CbGeAlD
Asenapine—HTR1D—brain—conduct disorder	0.000469	0.0241	CbGeAlD
Asenapine—HTR2C—brain—conduct disorder	0.000464	0.0239	CbGeAlD
Asenapine—ADRB1—brain—conduct disorder	0.000455	0.0235	CbGeAlD
Asenapine—SLC6A4—brain—conduct disorder	0.00044	0.0227	CbGeAlD
Asenapine—HTR2B—brain—conduct disorder	0.000436	0.0225	CbGeAlD
Asenapine—HTR1A—brain—conduct disorder	0.000391	0.0201	CbGeAlD
Asenapine—HTR7—brain—conduct disorder	0.000373	0.0192	CbGeAlD
Asenapine—ADRA1A—brain—conduct disorder	0.00036	0.0185	CbGeAlD
Asenapine—DRD2—brain—conduct disorder	0.000353	0.0182	CbGeAlD
Asenapine—ADRA2C—brain—conduct disorder	0.000343	0.0177	CbGeAlD
Asenapine—HRH1—brain—conduct disorder	0.000279	0.0144	CbGeAlD
Asenapine—ADRA2A—brain—conduct disorder	0.000274	0.0141	CbGeAlD
Asenapine—HTR2A—brain—conduct disorder	0.000233	0.012	CbGeAlD
Asenapine—CYP2D6—brain—conduct disorder	0.000212	0.0109	CbGeAlD
Asenapine—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	6.57e-05	0.000517	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	6.54e-05	0.000515	CbGpPWpGaD
Asenapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.53e-05	0.000514	CbGpPWpGaD
Asenapine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	6.49e-05	0.000511	CbGpPWpGaD
Asenapine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	6.48e-05	0.000511	CbGpPWpGaD
Asenapine—DRD4—GPCR ligand binding—HTR2A—conduct disorder	6.46e-05	0.000509	CbGpPWpGaD
Asenapine—DRD4—Circadian rythm related genes—EP300—conduct disorder	6.41e-05	0.000504	CbGpPWpGaD
Asenapine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.36e-05	0.0005	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—CGA—conduct disorder	6.17e-05	0.000486	CbGpPWpGaD
Asenapine—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	6.17e-05	0.000486	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	6.08e-05	0.000479	CbGpPWpGaD
Asenapine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.07e-05	0.000478	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—CGA—conduct disorder	6.07e-05	0.000478	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—CGA—conduct disorder	6.06e-05	0.000477	CbGpPWpGaD
Asenapine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	6.03e-05	0.000474	CbGpPWpGaD
Asenapine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	6.03e-05	0.000474	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	5.94e-05	0.000468	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—WASF1—conduct disorder	5.86e-05	0.000461	CbGpPWpGaD
Asenapine—HTR6—GPCR downstream signaling—DRD4—conduct disorder	5.85e-05	0.000461	CbGpPWpGaD
Asenapine—HTR7—GPCR downstream signaling—DRD4—conduct disorder	5.85e-05	0.00046	CbGpPWpGaD
Asenapine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	5.82e-05	0.000458	CbGpPWpGaD
Asenapine—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	5.81e-05	0.000457	CbGpPWpGaD
Asenapine—DRD1—Circadian rythm related genes—EP300—conduct disorder	5.77e-05	0.000454	CbGpPWpGaD
Asenapine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.77e-05	0.000454	CbGpPWpGaD
Asenapine—DRD3—GPCR ligand binding—HTR2A—conduct disorder	5.74e-05	0.000452	CbGpPWpGaD
Asenapine—DRD3—Circadian rythm related genes—EP300—conduct disorder	5.69e-05	0.000448	CbGpPWpGaD
Asenapine—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	5.69e-05	0.000448	CbGpPWpGaD
Asenapine—CYP1A2—Biological oxidations—COMT—conduct disorder	5.68e-05	0.000447	CbGpPWpGaD
Asenapine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.66e-05	0.000446	CbGpPWpGaD
Asenapine—CYP1A2—Biological oxidations—MAOA—conduct disorder	5.64e-05	0.000444	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CGA—conduct disorder	5.61e-05	0.000441	CbGpPWpGaD
Asenapine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	5.61e-05	0.000441	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CGA—conduct disorder	5.6e-05	0.000441	CbGpPWpGaD
Asenapine—HTR1E—GPCR downstream signaling—HTR2A—conduct disorder	5.59e-05	0.00044	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CGA—conduct disorder	5.56e-05	0.000438	CbGpPWpGaD
Asenapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.56e-05	0.000437	CbGpPWpGaD
Asenapine—HTR5A—Signaling Pathways—HTR2A—conduct disorder	5.55e-05	0.000437	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	5.52e-05	0.000435	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CGA—conduct disorder	5.45e-05	0.000429	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CGA—conduct disorder	5.36e-05	0.000422	CbGpPWpGaD
Asenapine—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	5.34e-05	0.000421	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—DRD4—conduct disorder	5.31e-05	0.000418	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—DRD4—conduct disorder	5.31e-05	0.000418	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—DRD4—conduct disorder	5.27e-05	0.000415	CbGpPWpGaD
Asenapine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	5.25e-05	0.000413	CbGpPWpGaD
Asenapine—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	5.23e-05	0.000412	CbGpPWpGaD
Asenapine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	5.18e-05	0.000408	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—DRD4—conduct disorder	5.16e-05	0.000407	CbGpPWpGaD
Asenapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.16e-05	0.000406	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CGA—conduct disorder	5.12e-05	0.000403	CbGpPWpGaD
Asenapine—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	5.12e-05	0.000403	CbGpPWpGaD
Asenapine—HTR1E—Signaling by GPCR—HTR2A—conduct disorder	5.08e-05	0.0004	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	5.04e-05	0.000397	CbGpPWpGaD
Asenapine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	5e-05	0.000394	CbGpPWpGaD
Asenapine—HRH2—GPCR downstream signaling—HTR2A—conduct disorder	4.98e-05	0.000392	CbGpPWpGaD
Asenapine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	4.98e-05	0.000392	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	4.97e-05	0.000391	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—DRD4—conduct disorder	4.85e-05	0.000382	CbGpPWpGaD
Asenapine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	4.84e-05	0.000381	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	4.84e-05	0.000381	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CGA—conduct disorder	4.83e-05	0.00038	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—CGA—conduct disorder	4.8e-05	0.000378	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CGA—conduct disorder	4.76e-05	0.000375	CbGpPWpGaD
Asenapine—UGT1A4—Metabolism—COMT—conduct disorder	4.62e-05	0.000364	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—DRD4—conduct disorder	4.6e-05	0.000362	CbGpPWpGaD
Asenapine—UGT1A4—Metabolism—MAOA—conduct disorder	4.59e-05	0.000361	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—DRD4—conduct disorder	4.58e-05	0.00036	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	4.53e-05	0.000357	CbGpPWpGaD
Asenapine—HRH2—Signaling by GPCR—HTR2A—conduct disorder	4.52e-05	0.000356	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—DRD4—conduct disorder	4.51e-05	0.000355	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—WASF1—conduct disorder	4.49e-05	0.000354	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—WASF1—conduct disorder	4.49e-05	0.000353	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	4.49e-05	0.000353	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—WASF1—conduct disorder	4.46e-05	0.000351	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	4.43e-05	0.000349	CbGpPWpGaD
Asenapine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	4.39e-05	0.000346	CbGpPWpGaD
Asenapine—CYP3A4—Biological oxidations—COMT—conduct disorder	4.39e-05	0.000345	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—WASF1—conduct disorder	4.37e-05	0.000344	CbGpPWpGaD
Asenapine—CYP3A4—Biological oxidations—MAOA—conduct disorder	4.36e-05	0.000343	CbGpPWpGaD
Asenapine—DRD2—Circadian rythm related genes—EP300—conduct disorder	4.35e-05	0.000343	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CGA—conduct disorder	4.34e-05	0.000342	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	4.33e-05	0.000341	CbGpPWpGaD
Asenapine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	4.33e-05	0.000341	CbGpPWpGaD
Asenapine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	4.31e-05	0.000339	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	4.31e-05	0.000339	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CGA—conduct disorder	4.3e-05	0.000338	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—WASF1—conduct disorder	4.3e-05	0.000338	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CGA—conduct disorder	4.24e-05	0.000334	CbGpPWpGaD
Asenapine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	4.23e-05	0.000333	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	4.19e-05	0.00033	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CGA—conduct disorder	4.15e-05	0.000327	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CGA—conduct disorder	4.13e-05	0.000325	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—DRD4—conduct disorder	4.11e-05	0.000324	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—WASF1—conduct disorder	4.1e-05	0.000323	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—DRD4—conduct disorder	4.09e-05	0.000322	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	4.08e-05	0.000321	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—DRD4—conduct disorder	4.02e-05	0.000317	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CGA—conduct disorder	4.02e-05	0.000316	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	3.93e-05	0.00031	CbGpPWpGaD
Asenapine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	3.93e-05	0.00031	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	3.91e-05	0.000308	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—CGA—conduct disorder	3.9e-05	0.000307	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—WASF1—conduct disorder	3.87e-05	0.000305	CbGpPWpGaD
Asenapine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	3.82e-05	0.000301	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—WASF1—conduct disorder	3.82e-05	0.0003	CbGpPWpGaD
Asenapine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	3.81e-05	0.0003	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	3.81e-05	0.0003	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	3.8e-05	0.000299	CbGpPWpGaD
Asenapine—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	3.79e-05	0.000298	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	3.74e-05	0.000295	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	3.73e-05	0.000294	CbGpPWpGaD
Asenapine—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	3.71e-05	0.000292	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	3.66e-05	0.000289	CbGpPWpGaD
Asenapine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	3.65e-05	0.000287	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CGA—conduct disorder	3.64e-05	0.000287	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CGA—conduct disorder	3.59e-05	0.000282	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CGA—conduct disorder	3.58e-05	0.000282	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CGA—conduct disorder	3.51e-05	0.000276	CbGpPWpGaD
Asenapine—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	3.49e-05	0.000274	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—WASF1—conduct disorder	3.48e-05	0.000274	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	3.47e-05	0.000273	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	3.46e-05	0.000273	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—DRD4—conduct disorder	3.45e-05	0.000272	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	3.45e-05	0.000271	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	3.44e-05	0.000271	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	3.41e-05	0.000268	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—WASF1—conduct disorder	3.4e-05	0.000268	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	3.4e-05	0.000268	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—DRD4—conduct disorder	3.39e-05	0.000267	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	3.37e-05	0.000265	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	3.33e-05	0.000262	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—WASF1—conduct disorder	3.33e-05	0.000262	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	3.32e-05	0.000261	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—WASF1—conduct disorder	3.31e-05	0.00026	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	3.29e-05	0.000259	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CGA—conduct disorder	3.26e-05	0.000257	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	3.24e-05	0.000255	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	3.22e-05	0.000253	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	3.17e-05	0.000249	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—DRD4—conduct disorder	3.14e-05	0.000247	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—DRD4—conduct disorder	3.14e-05	0.000247	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—DRD4—conduct disorder	3.12e-05	0.000245	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	3.09e-05	0.000243	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—DRD4—conduct disorder	3.05e-05	0.00024	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—HTR2A—conduct disorder	3e-05	0.000236	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	2.99e-05	0.000235	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	2.96e-05	0.000233	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	2.95e-05	0.000232	CbGpPWpGaD
Asenapine—HTR5A—Signaling Pathways—EP300—conduct disorder	2.94e-05	0.000232	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	2.93e-05	0.000231	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—WASF1—conduct disorder	2.92e-05	0.00023	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	2.89e-05	0.000228	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—WASF1—conduct disorder	2.87e-05	0.000226	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—WASF1—conduct disorder	2.87e-05	0.000226	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—DRD4—conduct disorder	2.87e-05	0.000226	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	2.83e-05	0.000223	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	2.81e-05	0.000221	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	2.81e-05	0.000221	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	2.74e-05	0.000215	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—DRD4—conduct disorder	2.7e-05	0.000213	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	2.68e-05	0.000211	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—HTR2A—conduct disorder	2.67e-05	0.00021	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—DRD4—conduct disorder	2.67e-05	0.00021	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	2.66e-05	0.000209	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	2.63e-05	0.000207	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	2.61e-05	0.000206	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	2.57e-05	0.000202	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	2.55e-05	0.000201	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CGA—conduct disorder	2.54e-05	0.0002	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	2.48e-05	0.000196	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	2.48e-05	0.000195	CbGpPWpGaD
Asenapine—ADRA2B—Hemostasis—EP300—conduct disorder	2.45e-05	0.000193	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	2.44e-05	0.000192	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—DRD4—conduct disorder	2.43e-05	0.000191	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	2.41e-05	0.00019	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.39e-05	0.000188	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—DRD4—conduct disorder	2.38e-05	0.000187	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.32e-05	0.000183	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.31e-05	0.000182	CbGpPWpGaD
Asenapine—ADRA2C—Hemostasis—EP300—conduct disorder	2.29e-05	0.000181	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.25e-05	0.000177	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.25e-05	0.000177	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.22e-05	0.000175	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.21e-05	0.000174	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.17e-05	0.000171	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—COMT—conduct disorder	2.17e-05	0.000171	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CGA—conduct disorder	2.15e-05	0.00017	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—MAOA—conduct disorder	2.15e-05	0.000169	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—HTR2A—conduct disorder	2.05e-05	0.000161	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—HTR2A—conduct disorder	2.05e-05	0.000161	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—DRD4—conduct disorder	2.04e-05	0.000161	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.03e-05	0.00016	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.02e-05	0.000159	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.01e-05	0.000158	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—DRD4—conduct disorder	2e-05	0.000158	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—HTR2A—conduct disorder	1.99e-05	0.000157	CbGpPWpGaD
Asenapine—UGT1A4—Metabolism—EP300—conduct disorder	1.98e-05	0.000156	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	1.97e-05	0.000155	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—HTR2A—conduct disorder	1.96e-05	0.000154	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—HTR2A—conduct disorder	1.87e-05	0.000147	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—EP300—conduct disorder	1.86e-05	0.000147	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	1.83e-05	0.000144	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—HTR2A—conduct disorder	1.76e-05	0.000139	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—COMT—conduct disorder	1.76e-05	0.000139	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—MAOA—conduct disorder	1.75e-05	0.000138	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—HTR2A—conduct disorder	1.74e-05	0.000137	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CGA—conduct disorder	1.66e-05	0.000131	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—EP300—conduct disorder	1.59e-05	0.000125	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—HTR2A—conduct disorder	1.59e-05	0.000125	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	1.57e-05	0.000124	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—HTR2A—conduct disorder	1.55e-05	0.000122	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.52e-05	0.000119	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.51e-05	0.000119	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.47e-05	0.000116	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—EP300—conduct disorder	1.42e-05	0.000111	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.33e-05	0.000105	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.31e-05	0.000103	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.28e-05	0.000101	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.19e-05	9.38e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—COMT—conduct disorder	1.15e-05	9.03e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—MAOA—conduct disorder	1.14e-05	8.97e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—EP300—conduct disorder	1.09e-05	8.54e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—EP300—conduct disorder	1.08e-05	8.53e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—EP300—conduct disorder	1.08e-05	8.48e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—EP300—conduct disorder	1.05e-05	8.3e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—EP300—conduct disorder	1.04e-05	8.17e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—EP300—conduct disorder	9.91e-06	7.8e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—COMT—conduct disorder	9.72e-06	7.65e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MAOA—conduct disorder	9.65e-06	7.6e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	9.36e-06	7.37e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—EP300—conduct disorder	9.34e-06	7.36e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—EP300—conduct disorder	9.3e-06	7.32e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—EP300—conduct disorder	9.22e-06	7.26e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—EP300—conduct disorder	8.4e-06	6.61e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—EP300—conduct disorder	8.32e-06	6.55e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—EP300—conduct disorder	8.22e-06	6.47e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EP300—conduct disorder	8.03e-06	6.32e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EP300—conduct disorder	7.99e-06	6.29e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EP300—conduct disorder	7.77e-06	6.12e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—EP300—conduct disorder	7.55e-06	5.94e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—COMT—conduct disorder	7.5e-06	5.91e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MAOA—conduct disorder	7.45e-06	5.86e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EP300—conduct disorder	7.05e-06	5.55e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EP300—conduct disorder	6.94e-06	5.46e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EP300—conduct disorder	6.93e-06	5.45e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EP300—conduct disorder	6.8e-06	5.35e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EP300—conduct disorder	6.31e-06	4.97e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—EP300—conduct disorder	4.92e-06	3.87e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—EP300—conduct disorder	4.17e-06	3.28e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—EP300—conduct disorder	3.22e-06	2.53e-05	CbGpPWpGaD
